The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-hydroxy-2-[[2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-1H-pyrido[1,2-a]pyrazin-8-one ID: ALA4556206
PubChem CID: 129165377
Max Phase: Preclinical
Molecular Formula: C16H15F3N2O2
Molecular Weight: 324.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1cc2n(cc1O)CCN(Cc1ccccc1C(F)(F)F)C2
Standard InChI: InChI=1S/C16H15F3N2O2/c17-16(18,19)13-4-2-1-3-11(13)8-20-5-6-21-10-15(23)14(22)7-12(21)9-20/h1-4,7,10,23H,5-6,8-9H2
Standard InChI Key: JBRCWPPLLMSMCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.9332 -25.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9332 -26.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3438 -25.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6385 -25.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3438 -26.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6366 -26.8111 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6303 -27.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3295 -28.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0368 -27.6322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0447 -26.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6385 -24.3630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2243 -25.1864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7408 -28.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4521 -27.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1540 -28.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8648 -27.6626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8724 -26.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1634 -26.4299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4555 -26.8339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1440 -28.8814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4314 -29.2813 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.8467 -29.2986 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.1389 -29.6954 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 4 1 0
2 6 1 0
5 3 2 0
3 4 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
4 11 2 0
1 12 1 0
9 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
15 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.30Molecular Weight (Monoisotopic): 324.1086AlogP: 2.59#Rotatable Bonds: 2Polar Surface Area: 45.47Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.45CX Basic pKa: 5.67CX LogP: 2.70CX LogD: 2.70Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.92Np Likeness Score: -0.96
References 1. Ernst G, Akuma D, Au V, Buchler IP, Byers S, Carr GV, Defays S, de León P, Demaude T, DePasquale M, Durieu V, Huang Y, Jigorel E, Kimos M, Kolobova A, Montel F, Moureau F, Poslusney M, Swinnen D, Vandergeten MC, Van Houtvin N, Wei H, White N, Wood M, Barrow JC.. (2019) Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O -Methyltransferase., 10 (11): [PMID:32038769 ] [10.1021/acsmedchemlett.9b00345 ]